FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
From - Diagnostic Testing & Emerging Technologies
A joint guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and…
From - Diagnostic Testing & Emerging Technologies
The majority of women are willing to undergo less frequent cervical cancer screening, consistent with screening guidelines, if it was…
From - Diagnostic Testing & Emerging Technologies
Large-scale sequencing initiatives performed in integrated health care systems, such as the DiscovEHR collaboration, can advance genetic discovery and serve as a…
From - Diagnostic Testing & Emerging Technologies
Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations, according to a research letter published Feb…
From - Diagnostic Testing & Emerging Technologies
The case has been made repeatedly over the past few years regarding the need to increase physicians' genomics knowledge. Now, for the first time…